Background: We investigated whether fascia knife release therapy combined with exercise for treating neck and shoulder pain administered over a period of 12 weeks enhanced the visual analog scale (VAS ...

PARAMUS, N.J., Oct. 14, 2025 /PRNewswire/ -- NS Pharma, Inc. (NS Pharma), a biopharmaceutical leader in rare disease and subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that ...

Find out the symptoms of Lauren's deadly condition to look out for below WHEN fitness fanatic Lauren Carson began experiencing back pain, she shrugged it off as a pulled muscle from running. Just ...

A young woman was given just hours to live after kidney stones caused by a urinary tract infection sent her body into septic shock. In August, Lauren Carson, 31, from Belfast, woke up with a urinary ...

Gerald Coetzee's participation for the upcoming white-ball series against Pakistan might be under doubt after he injured himself during the one-off T20I between Namibia and South Africa on Saturday, ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

Abstract: Tissue engineering techniques and particularly in situ bioprinting using handheld devices and robotic systems have recently demonstrated promising outcomes to address volumetric muscle loss ...

Basking in the glow of a collaboration involving Eli Lilly’s diabetes/weight loss blockbuster tirzepatide, BioAge Labs has completed an oversubscribed $170 million Series D financing, the proceeds of ...

GLD Partners has secured access to Heligenics’ GigaAssay platform to launch Altagenics, a startup with ambitions to develop first-in-class medicines for muscle-wasting conditions. Altagenics will use ...

Long-term treatment with givinostat in boys with Duchenne muscular dystrophy continues to show a favourable safety and tolerability profile MILAN, Italy, October 07, 2025 – Italfarmaco S.p.A.

Vienna — The investigational monoclonal antibody trevogrumab was associated with lean mass preservation and greater loss of fat mass in people taking semaglutide, an interim trial data showed.